The global Hospital Infection Therapeutics market was valued at US$ 2803.3 million in 2022 and is projected to reach US$ 3303.6 million by 2029, at a CAGR of 2.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infections.
This report aims to provide a comprehensive presentation of the global market for Hospital Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Infection Therapeutics. This report contains market size and forecasts of Hospital Infection Therapeutics in global, including the following market information:
- Global Hospital Infection Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Infection Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Infection Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Hospital Infection Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Antibacterial Drugs
- Antiviral Drugs
- Antifungal Drugs
Global Hospital Infection Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Hospital Infection Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospital Acquired Pneumonia
- Surgical Site Infections
- Urinary Tract Infection
- Gastrointestinal Disorders
- Bloodstream Infections
- Others
Global Hospital Infection Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Hospital Infection Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital Infection Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital Infection Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- Johnson & Johnson Services
- Actavis
- Sanofi
- Bristol Myers Squibb Company
- AstraZeneca
- Pfizer
- Merck
- GlaxoSmithkline
- Cubist Pharmaceuticals
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Hospital Infection Therapeutics, market overview.
- Chapter 2: Global Hospital Infection Therapeutics market size in revenue.
- Chapter 3: Detailed analysis of Hospital Infection Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Hospital Infection Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital Infection Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Infection Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Infection Therapeutics Overall Market Size
2.1 Global Hospital Infection Therapeutics Market Size: 2022 VS 2032
2.2 Global Hospital Infection Therapeutics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Infection Therapeutics Players in Global Market
3.2 Top Global Hospital Infection Therapeutics Companies Ranked by Revenue
3.3 Global Hospital Infection Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hospital Infection Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hospital Infection Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Infection Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Hospital Infection Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Infection Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital Infection Therapeutics Market Size Markets, 2022 & 2032
4.1.2 Antibacterial Drugs
4.1.3 Antiviral Drugs
4.1.4 Antifungal Drugs
4.2 By Type - Global Hospital Infection Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Hospital Infection Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Hospital Infection Therapeutics Revenue, 2024-2032
4.2.3 By Type - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Infection Therapeutics Market Size, 2022 & 2032
5.1.2 Hospital Acquired Pneumonia
5.1.3 Surgical Site Infections
5.1.4 Urinary Tract Infection
5.1.5 Gastrointestinal Disorders
5.1.6 Bloodstream Infections
5.1.7 Others
5.2 By Application - Global Hospital Infection Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Hospital Infection Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Hospital Infection Therapeutics Revenue, 2024-2032
5.2.3 By Application - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Hospital Infection Therapeutics Market Size, 2022 & 2032
6.2 By Region - Global Hospital Infection Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Hospital Infection Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Hospital Infection Therapeutics Revenue, 2024-2032
6.2.3 By Region - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Hospital Infection Therapeutics Revenue, 2018-2032
6.3.2 US Hospital Infection Therapeutics Market Size, 2018-2032
6.3.3 Canada Hospital Infection Therapeutics Market Size, 2018-2032
6.3.4 Mexico Hospital Infection Therapeutics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Hospital Infection Therapeutics Revenue, 2018-2032
6.4.2 Germany Hospital Infection Therapeutics Market Size, 2018-2032
6.4.3 France Hospital Infection Therapeutics Market Size, 2018-2032
6.4.4 U.K. Hospital Infection Therapeutics Market Size, 2018-2032
6.4.5 Italy Hospital Infection Therapeutics Market Size, 2018-2032
6.4.6 Russia Hospital Infection Therapeutics Market Size, 2018-2032
6.4.7 Nordic Countries Hospital Infection Therapeutics Market Size, 2018-2032
6.4.8 Benelux Hospital Infection Therapeutics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Hospital Infection Therapeutics Revenue, 2018-2032
6.5.2 China Hospital Infection Therapeutics Market Size, 2018-2032
6.5.3 Japan Hospital Infection Therapeutics Market Size, 2018-2032
6.5.4 South Korea Hospital Infection Therapeutics Market Size, 2018-2032
6.5.5 Southeast Asia Hospital Infection Therapeutics Market Size, 2018-2032
6.5.6 India Hospital Infection Therapeutics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Hospital Infection Therapeutics Revenue, 2018-2032
6.6.2 Brazil Hospital Infection Therapeutics Market Size, 2018-2032
6.6.3 Argentina Hospital Infection Therapeutics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Infection Therapeutics Revenue, 2018-2032
6.7.2 Turkey Hospital Infection Therapeutics Market Size, 2018-2032
6.7.3 Israel Hospital Infection Therapeutics Market Size, 2018-2032
6.7.4 Saudi Arabia Hospital Infection Therapeutics Market Size, 2018-2032
6.7.5 UAE Hospital Infection Therapeutics Market Size, 2018-2032
7 Hospital Infection Therapeutics Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Hospital Infection Therapeutics Major Product Offerings
7.1.4 Bayer Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Johnson & Johnson Services
7.2.1 Johnson & Johnson Services Company Summary
7.2.2 Johnson & Johnson Services Business Overview
7.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Major Product Offerings
7.2.4 Johnson & Johnson Services Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Services Key News & Latest Developments
7.3 Actavis
7.3.1 Actavis Company Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Hospital Infection Therapeutics Major Product Offerings
7.3.4 Actavis Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Actavis Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Hospital Infection Therapeutics Major Product Offerings
7.4.4 Sanofi Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Bristol Myers Squibb Company
7.5.1 Bristol Myers Squibb Company Company Summary
7.5.2 Bristol Myers Squibb Company Business Overview
7.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Major Product Offerings
7.5.4 Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Bristol Myers Squibb Company Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Hospital Infection Therapeutics Major Product Offerings
7.6.4 AstraZeneca Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Hospital Infection Therapeutics Major Product Offerings
7.7.4 Pfizer Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Hospital Infection Therapeutics Major Product Offerings
7.8.4 Merck Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 GlaxoSmithkline
7.9.1 GlaxoSmithkline Company Summary
7.9.2 GlaxoSmithkline Business Overview
7.9.3 GlaxoSmithkline Hospital Infection Therapeutics Major Product Offerings
7.9.4 GlaxoSmithkline Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithkline Key News & Latest Developments
7.10 Cubist Pharmaceuticals
7.10.1 Cubist Pharmaceuticals Company Summary
7.10.2 Cubist Pharmaceuticals Business Overview
7.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Major Product Offerings
7.10.4 Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Cubist Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital Infection Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hospital Infection Therapeutics Market Drivers in Global Market
Table 3. Hospital Infection Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hospital Infection Therapeutics in Global Market
Table 5. Top Hospital Infection Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hospital Infection Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hospital Infection Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hospital Infection Therapeutics Product Type
Table 9. List of Global Tier 1 Hospital Infection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Infection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Hospital Infection Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hospital Infection Therapeutics Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hospital Infection Therapeutics Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hospital Infection Therapeutics Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hospital Infection Therapeutics Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hospital Infection Therapeutics Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hospital Infection Therapeutics Revenue, (US$, Mn), 2024-2032
Table 30. Bayer Company Summary
Table 31. Bayer Hospital Infection Therapeutics Product Offerings
Table 32. Bayer Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Johnson & Johnson Services Company Summary
Table 35. Johnson & Johnson Services Hospital Infection Therapeutics Product Offerings
Table 36. Johnson & Johnson Services Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Services Key News & Latest Developments
Table 38. Actavis Company Summary
Table 39. Actavis Hospital Infection Therapeutics Product Offerings
Table 40. Actavis Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Actavis Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Hospital Infection Therapeutics Product Offerings
Table 44. Sanofi Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Bristol Myers Squibb Company Company Summary
Table 47. Bristol Myers Squibb Company Hospital Infection Therapeutics Product Offerings
Table 48. Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Bristol Myers Squibb Company Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Hospital Infection Therapeutics Product Offerings
Table 52. AstraZeneca Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Hospital Infection Therapeutics Product Offerings
Table 56. Pfizer Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Hospital Infection Therapeutics Product Offerings
Table 60. Merck Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. GlaxoSmithkline Company Summary
Table 63. GlaxoSmithkline Hospital Infection Therapeutics Product Offerings
Table 64. GlaxoSmithkline Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithkline Key News & Latest Developments
Table 66. Cubist Pharmaceuticals Company Summary
Table 67. Cubist Pharmaceuticals Hospital Infection Therapeutics Product Offerings
Table 68. Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Cubist Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Hospital Infection Therapeutics Segment by Type in 2022
Figure 2. Hospital Infection Therapeutics Segment by Application in 2022
Figure 3. Global Hospital Infection Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital Infection Therapeutics Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Hospital Infection Therapeutics Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Infection Therapeutics Revenue in 2022
Figure 8. By Type - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 9. By Application - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 10. By Type - Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 12. By Application - Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 14. By Region - Global Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 15. By Country - North America Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 16. US Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 20. Germany Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 21. France Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 28. China Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 32. India Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 34. Brazil Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Hospital Infection Therapeutics Revenue Market Share, 2018-2032
Figure 37. Turkey Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Hospital Infection Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 41. Bayer Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Services Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Actavis Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithkline Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
